Latest Ipo News

Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.

Sea Forest Limited (ASX:SEA) reported a spectacular 486% surge in SeaFeed revenue for FY26, underpinned by 131,000 cattle committed, surpassing breakeven targets, and a robust $27.8 million cash buffer. The company advances its commercial footprint domestically and internationally, with carbon credit revenue set to kick off in late 2027.

Green & Gold Minerals posted a $886,828 loss for FY2026 amid a transformative year marked by its ASX listing and expansion into base metals exploration with the Herberton acquisition.

Almasar Minerals Limited (ASX:AMK) is launching an IPO to fund early-stage exploration across five licences in Saudi Arabia’s Arabian Shield, targeting gold and copper mineralisation.

Pengana Private Equity Trust (ASX: PE1) posted a 23.2% net return for FY2026, powered by a dramatic revaluation of SpaceX and strong gains across a diversified private equity portfolio.

L1 Long Short Fund Limited (ASX:LSF) posted a standout FY26 with a 45.4% net portfolio return, driving a 538% jump in net profit after tax to $635 million and a 22% CAGR in dividends since IPO. The fund also released its inaugural climate-related disclosures, affirming resilience amid evolving risks.

The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.

Epiminder Limited reported a $42.7 million loss for FY26, driven by clinical trial and product development costs following a $125 million IPO. The company progresses its FDA-approved Minder implantable EEG monitor with a pivotal US trial and next-gen device on track for 2028 launch.

Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.

AIX has acquired an 8% holding in AI powerhouse Databricks during its US$5 billion funding round, marking a significant expansion in the trust’s AI-focused portfolio.

WAM Income Maximiser has secured $172.4 million through a multi-part capital raise, increasing its assets by more than half and maintaining a strong fully franked dividend yield.

SkinKandy posted a strong debut full year as a listed company, growing revenue to $90.2 million and net profit to $9 million, both ahead of Prospectus expectations, driven by aggressive store expansion and robust same-store sales.